Fingolimod Effect on Cytokine and Chemokine Levels

Clinical trial NCT02373098 · COMPLETED

Trial details

NCT number: NCT02373098
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Relapsing Remitting Multiple Sclerosis

Start date: 2015-03-31
Primary completion: 2017-01-18
Enrollment: 126

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.